supernus.com (SUPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Supernus Pharmaceuticals - SUPN emitenti grafik logotipi

Quyida tasvirlangan Supernus Pharmaceuticals (SUPN) aksiyalari narxi, ADHD va epilepsiya davolash vositalariga bo'lgan uzoq muddatli talabga tayanadigan va barqaror pul oqimlarini ta'minlaydigan biznesning chidamliligini baholashga yordam beradi. Joriy ko'rsatkich 0.03 ni tashkil etadi. Jack Hatigian jamoasi yangi ishlanmalarni samarali joriy qilmoqda va patentlarni himoya qilmoqda. Shu bilan birga, Supernus Pharmaceuticals o'z dori vositalarining terapevtik imkoniyatlarini kengaytirish orqali iste'molchilar bazasini oshirib, yangi bozorlarni egallamoqda.

Supernus Pharmaceuticals, Inc. (SUPN): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 31.10.2026gacha

Supernus Pharmaceuticals kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Supernus Pharmaceuticals, Inc.|SUPN - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Supernus Pharmaceuticals|SUPN - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Supernus|SUPN - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati supernus.com|SUPN - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Supernus Pharmaceuticals|SUPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti supernus.com|SUPN - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Supernus Pharmaceuticals|SUPN - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Supernus|Shoshilinch likvidlik supernus.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
SUPN - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:SUPN, Supernus Pharmaceuticals, Inc.
Supernus original mahsuloti

ESG standartlarini markaziy nerv tizimi (CNS) dori vositalarini ishlab chiqishga integratsiya qilish barqaror moliyalashtirishni talab etadi, bu tendentsiya uzoq muddatli qarzdorlikning kapitalga nisbati ko'rsatkichida aks etgan. Ushbu ko'rsatkich bir yildan ortiq muddatli majburiyatlarni umumiy kapital bilan bog'laydi, bu esa tahlilchilarga M&A bitimlari davomida spekulyativ tebranishlarni fundamental qarz yukidan ajratish imkonini beradi. Past qiymat Supernus Pharmaceuticals (SUPN) moliyaviy barqarorligini tasdiqlaydi va inqiroz davrida xavfsizlikni ta'minlaydi.

Raqobatdosh kompaniyalar tahlili

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Catalyst Pharmaceuticals Inc (CPRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Denali Corp (DNLI)|Uzoq muddatli qarzning o'z kapitaliga nisbati Harmony Biosciences|biohavenpharma.com (BHVN) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AMLX (Amylyx Pharmaceuticals, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Trevi Therapeutics Inc (TRVI)|Uzoq muddatli qarzning o'z kapitaliga nisbati Praxis Medicines PRAX|AVXL (Anavex Life Sciences Corp) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|CeriBell, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Prothena Corporation PLC|alector.com (ALEC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Annexon Biosciences - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Omeros Corp|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NGNE (Neurogene Therapeutics)|Uzoq muddatli qarzning o'z kapitaliga nisbati ACIU (AC Immune)|Uzoq muddatli qarzning kapitalga nisbati voyagertherapeutics.com (VYGR)|Uzoq muddatli qarzning o'z kapitaliga nisbati Neumora Therapeutics, Inc. NMRA|Uzoq muddatli qarzdorlikning kapitalga nisbati Scilex Holding (SCLX)|TVGN: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACOG (Alpha Cognition)|Cognition Therapeutics (CGTX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati IKT (inhibikase.com)|SAVA (Cassava Sciences) - Uzoq muddatli qarzning kapitalga nisbati|ASRT: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati COYA|Uzoq muddatli qarzning kapitalga nisbati vistagen.com (VTGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ovid Therapeutics OVID|Uzoq muddatli qarzning kapitalga koeffitsiyenti ABOS|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alterity Therapeutics (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLNN: Uzoq muddatli qarzning kapitalga nisbati|PepGen (PEPG) - Uzoq muddatli qarzning kapitalga nisbati|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati relmada.com (RLMD)|Uzoq muddatli qarzning kapitalga nisbati ANVS|GRCE - Uzoq muddatli majburiyatlarning kapitalga nisbati|Firefly Neuroscience Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANEW Medical KLTO|NRSN: Uzoq muddatli qarzning o'z kapitaliga nisbati|revivapharma.com - Uzoq muddatli kreditlarning kapitalga nisbati|MTVA: Uzoq muddatli qarzning kapitalga nisbati|NRXS - Uzoq muddatli qarzdorlikning kapitalga nisbati|HSDT (Helius Medical Technologies, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio Corp (PASG)|Uzoq muddatli qarzning kapitalga nisbati NEUP|Uzoq muddatli qarzning kapitalga nisbati minervaneurosciences.com (NERV)|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|Addex Therapeutics Ltd. - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cyclerion Therapeutics CYCN|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning kapitalga nisbati Avenue Therapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|ELYM: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH (Longboard Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|MRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|Uzoq muddatli qarzning kapitalga nisbati sagerx.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN (Trevena Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati